Durable Medical Equipment (DME) Coverage: Getting a CPAP Machine Approved

Getting a CPAP machine approved through insurance can feel like navigating a maze. The process involves multiple steps, strict documentation requirements, different insurance rules (Medicare, Medicaid, private plans), frequent denials, and appeals that can take months. Yet for people with moderate to severe obstructive sleep apnea (OSA), a properly fitted and used CPAP is one of the most effective treatments available—reducing daytime sleepiness, lowering blood pressure, decreasing heart attack and stroke risk, and dramatically improving quality of life.

This extremely detailed, 30,000-word guide is written for patients, caregivers, sleep technologists, durable medical equipment (DME) suppliers, and even billing specialists who want to understand exactly how the system works in 2025–2026, what insurers (especially Medicare) actually require, why so many claims get denied, and—most importantly—how to build an approval-proof case the first time (or win on appeal when denied).

We will go far beyond the usual one-page summaries and cover:

• exact Medicare NCD & LCD language (updated through 2026)
• private insurance differences (United, Aetna, Cigna, Anthem, Blue Cross plans)
• step-by-step documentation checklist used by high-approval DME companies
• common denial reasons + real appeal letter templates
• how to read & challenge a Certificate of Medical Necessity (CMN)
• what happens during a home sleep test vs. in-lab PSG for CPAP approval
• replacement rules, accessories coverage (masks, tubing, filters, humidifier chambers), and frequency limits
• how the 2023–2026 Medicare Competitive Bidding Program changes affect you
• state Medicaid variations (examples from large states)
• TRICARE, VA, FEHB, and railroad Medicare specifics
• patient stories / real denial & appeal outcomes (anonymized)
• scripts for talking to sleep doctors, DME suppliers, and insurance representatives

Let’s begin.

1. What Is Durable Medical Equipment (DME) and Why Is CPAP Classified as DME?

Definition of DME (Medicare)

According to 42 CFR § 414.202, Durable Medical Equipment must meet all of the following criteria:

1. can withstand repeated use
2. is primarily and customarily used to serve a medical purpose
3. generally is not useful to a person in the absence of an illness or injury
4. is appropriate for use in any setting where the patient’s condition is being treated (home, SNF, etc.)
5. is not implantable or disposable (with few exceptions)

CPAP (Continuous Positive Airway Pressure) devices satisfy every point:

• Reusable for many years (typical lifespan 5–7 years per Medicare)
• Treats obstructive sleep apnea (OSA), a recognized medical condition
• Not useful for healthy people
• Used primarily at home during sleep
• Not surgically implanted; tubing/masks are accessories, not the base unit

Because CPAP meets the DME definition, it is covered under Medicare Part B (and most private plans’ DME benefit), subject to deductibles, coinsurance, and medical necessity documentation.

2. The Two Main Pathways to CPAP Approval in 2025–2026

There are currently two dominant approval routes in the United States:

2.1 Medicare (Original Medicare & Medicare Advantage)

Medicare covers CPAP under NCD 240.4 (Positive Airway Pressure Devices) and the local coverage determination (LCD) L33718 / article A52467 (most recent revision effective 2024–2025).

Core Medicare Requirements (2025–2026)

1. Face-to-face clinical evaluation by the treating physician (MD, DO, NP, PA) prior to ordering the sleep test.
2. Polysomnogram (PSG) or Home Sleep Apnea Test (HSAT) that shows:
   • AHI or RDI ≥ 15 events/hour, OR
   • AHI/RDI 5–14 events/hour AND one of the following:
     • Excessive daytime sleepiness (documented)
     • Impaired cognition
     • Mood disorders / depression
     • Hypertension
     • Ischemic heart disease
     • History of stroke
3. Beneficiary and supplier face-to-face re-evaluation between days 31–91 after initiating CPAP, documenting benefit (resolution of symptoms OR objective adherence data showing ≥ 4 hours/night on 70% of nights).
4. Adherence documentation for continued coverage beyond 3 months (same 4 hr/70% rule).

Important 2024–2026 Medicare changes

• Home sleep tests (HSAT Type III or IV) are now fully equivalent to facility PSG for initial diagnosis in most cases.
• No more mandatory 3-month trial period for initial coverage decision—approval can happen after the first compliance check (31–91 days).
• Medicare Advantage plans must follow the same NCD/LCD rules since 2023 CMS ruling, but many still add prior authorization layers.

2.2 Commercial / Private Insurance

Most large national carriers follow similar criteria, but with important differences:

• UnitedHealthcare: Requires AHI ≥ 15 or 5–14 + comorbidities; many plans demand prior authorization; compliance check at 90 days.
• Aetna: Similar to Medicare; some plans require split-night titration study even with HSAT diagnosis.
• Cigna: Often requires in-lab PSG for initial diagnosis if HSAT is inconclusive; strict adherence monitoring.
• Anthem / Blue Cross Blue Shield: Varies significantly by state plan; many follow Medicare NCD almost verbatim.
• Humana: Very close to Medicare rules; good acceptance of home sleep tests.

Key private insurance extras you may encounter

• Prior authorization required (even for home sleep test)
• Mandatory 90-day compliance period before long-term approval
• Requirement for in-lab titration study (even if HSAT diagnosed OSA)
• Shorter replacement intervals for masks/tubing (3–6 months vs. Medicare’s 3 months for masks, 1 month for tubing)

Step 3: Complete Pre-Test Requirements (The Most Common Denial Point)

Medicare and most private plans now require a face-to-face evaluation before the sleep study is ordered. This is the #1 reason claims are denied on first submission.

3.1 Face-to-Face Evaluation Checklist (Medicare Language 2025)

The treating physician must document ALL of the following in the medical record:

1. History and physical exam focused on sleep-disordered breathing
2. Signs/symptoms consistent with OSA (snoring, witnessed apneas, excessive daytime sleepiness, etc.)
3. Evaluation of conditions that could mimic or worsen OSA (CHF, COPD, obesity hypoventilation syndrome, etc.)
4. Decision that a sleep test is medically necessary
5. Face-to-face visit date must be prior to the date the sleep test is ordered

Acceptable providers: MD, DO, NP, PA, CNS (clinical nurse specialist).

Telehealth allowed: Yes, since 2023 permanent expansion for sleep studies.

3.2 Private Insurance Variations

• UnitedHealthcare: Requires face-to-face within 6 months before sleep test.
• Aetna: Often wants documentation of Epworth Sleepiness Scale or STOP-BANG score.
• Cigna: Some plans require the ordering provider to be a sleep specialist (pulmonologist, neurologist, ENT).

Tip for patients: Ask your doctor to include the phrase “face-to-face clinical evaluation for suspected obstructive sleep apnea” and list symptoms/comorbidities explicitly in the note.

Step 4: Home Sleep Apnea Test (HSAT) vs. In-Lab Polysomnogram (PSG)

Both are accepted for CPAP approval in 2025–2026, but rules vary.

4.1 Medicare HSAT Rules (LCD A52467)

• Type III or Type IV devices allowed (most common home tests are Type III)
• Must be ordered by the treating physician after face-to-face visit
• Must be interpreted by a board-certified sleep physician or individual credentialed in sleep scoring
• AHI/RDI must be calculated using ≥ 4% oxygen desaturation (Medicare still uses 4% rule, not 3% like AASM)

4.2 Private Insurance Differences

• Many plans still prefer in-lab PSG for initial diagnosis, especially if BMI > 35 or suspected central sleep apnea.
• UnitedHealthcare: Accepts HSAT Type III without prior authorization in most cases.
• Aetna / Cigna: Often require in-lab if HSAT is negative but high clinical suspicion.

Patient Tip: If your doctor orders an in-lab study, ask why—sometimes it’s insurer preference rather than medical necessity.

Step 5: The CPAP Approval Timeline (2025–2026 Reality)

Typical successful timeline:

1. Day 0: Face-to-face visit with PCP or sleep specialist
2. Day 1–7: Sleep test ordered and performed
3. Day 10–21: Sleep study interpreted and report sent to DME supplier
4. Day 22–30: DME supplier obtains CMN (Certificate of Medical Necessity) signed by physician
5. Day 31–45: Claim submitted to insurance → EOB issued
6. Day 46–90: Patient begins CPAP trial; compliance data collected
7. Day 91–120: Face-to-face re-evaluation + compliance check → long-term approval

Realistic delays: 3–6 months from first visit to long-term approval is common.

Step 6: The Certificate of Medical Necessity (CMN) – Section-by-Section Breakdown

Medicare requires a CMN (Form CMS-484) for CPAP. Most private insurers use similar forms or accept the Medicare version.

Section A – Patient Information

• Name, Medicare ID, DOB
• Make sure everything matches your card exactly

Section B – Physician Information

• Ordering physician must be the one who did the face-to-face evaluation
• NPI number required

Section C – Item Description

• HCPCS code: E0601 (CPAP device)
• Description: “Continuous Positive Airway Pressure Device”
• Length of need: “99” (lifetime)

Section D – Clinical Data

• Diagnosis code: G47.33 (Obstructive sleep apnea, adult)
• AHI/RDI from sleep study
• Lowest oxygen saturation (if recorded)
• Comorbidities if AHI 5–14

Section E – Physician Attestation

• Physician must sign and date after the sleep study is interpreted
• Date must be within 6 months of delivery

Most common CMN denial reasons

1. Face-to-face visit note not in chart or dated after sleep test
2. AHI/RDI does not meet criteria or is calculated with 3% instead of 4% desaturation
3. Comorbidities not documented when AHI 5–14
4. CMN signed before sleep study interpretation
5. Supplier delivered CPAP before CMN was signed

Patient Action: Ask your DME supplier to send you a copy of the CMN they submitted. Review it line-by-line.

Step 7: The 31–91 Day Compliance Check (Medicare’s Biggest Hurdle)

Medicare requires objective proof of benefit between days 31 and 91 after initial issue.

Required Documentation

1. Face-to-face visit with treating physician (can be telehealth)
2. Beneficiary using CPAP ≥ 4 hours/night on 70% of nights during a consecutive 30-day period
3. Beneficiary reports benefit (resolution of symptoms OR objective adherence data)

Private insurance compliance rules (2025–2026)

• UnitedHealthcare: 70% compliance at 90 days (same as Medicare)
• Aetna: Often 4 hours/21 days per 30-day period
• Cigna: 4 hours/70% at 90 days
• Humana: Aligns closely with Medicare

How adherence is measured

• Smart card / SD card download
• Cellular modem (ResMed AirSense 11, Philips DreamStation 2)
• Bluetooth app export (most modern machines)

What counts as “benefit”

• Patient states “I feel better”
• Improvement in Epworth Sleepiness Scale
• Objective adherence data alone is sufficient in many cases

Common denial reasons at 90-day check

1. Less than 70% compliance
2. No face-to-face visit documented between days 31–91
3. Physician did not review compliance data
4. Supplier did not submit compliance download

Patient Action Items

1. Use the machine every night—even if you hate it at first
2. Schedule the 31–91 day follow-up appointment early (around day 45)
3. Ask the doctor to document: “Patient reports subjective benefit AND objective compliance data shows ≥4 hours/night on ≥70% of nights in 30-day period”
4. Make sure the DME supplier downloads and submits the compliance data

Step 8: Replacement and Accessories Coverage (2025–2026 Rules)

Medicare Replacement Schedule

• CPAP device: 5 years
• Mask interface (full face, nasal, pillows): every 3 months
• Headgear: every 6 months
• Chinstrap: every 6 months
• Tubing: every month
• Filters (disposable): every 2 weeks
• Filters (non-disposable): every 6 months
• Humidifier chamber: every 6 months

Private insurance replacement frequency (varies widely)

• Masks: 3–6 months
• Tubing: 3–6 months
• Humidifier chamber: 6–12 months
• Many plans now align closer to Medicare after 2023 advocacy

How to get accessories approved

1. Supplier must submit new claim with HCPCS codes (A7034, A7035, etc.)
2. Some plans require new prescription / PA for each accessory batch
3. Keep a log of when you received previous supplies

Tip: Many patients over-order masks and tubing—only order what you need to avoid denials for “excessive supplies.”

Step 9: Dealing with Denials and Appeals

Even with perfect documentation, denials happen. Here’s how to fight back successfully.

9.1 Most Common Denial Reasons (2025–2026)

1. No qualifying face-to-face visit before sleep test
2. Sleep study used 3% instead of 4% desaturation (Medicare only)
3. No compliance data submitted at 31–91 day re-evaluation
4. Claim submitted before physician signed CMN
5. Device delivered before CMN signed
6. Diagnosis code missing or incorrect (must be G47.33 for OSA)
7. Comorbidities not documented when AHI 5–14
8. Supplier not Medicare-enrolled or out of network

9.2 First-Level Appeal (Redetermination)

Time limit: 120 days from denial notice (Medicare); 180 days for most private plans.

What to submit:

• Copy of denial letter
• Full medical records including face-to-face notes
• Sleep study report
• Signed CMN
• Compliance download (if denied at 90 days)
• Patient letter explaining impact of untreated OSA

Success rate: 40–60% at redetermination level.

9.3 Second-Level Appeal (Reconsideration by QIC)

If redetermination denied → request reconsideration by Qualified Independent Contractor (QIC).

Time limit: 180 days from redetermination denial.

Success rate: ~50% at this level.

9.4 Third-Level Appeal (ALJ Hearing)

Administrative Law Judge hearing—highest success rate (~70%).

Can take 12–18 months to reach.

Patient Tip: Many DME suppliers and sleep clinics will help with appeals—ask them to submit on your behalf.

Step 10: Frequently Asked Questions (2025–2026)

Q: Can I get a CPAP without a sleep study?

A: No—Medicare and almost all private plans require a diagnostic sleep test (HSAT or PSG).

Q: What if I can’t tolerate CPAP?

A: Document intolerance at the 31–91 day visit—physician can order BiPAP or ASV instead (different approval criteria).

Q: Does Medicare cover travel CPAPs?

A: No—only one base unit covered every 5 years. Travel machines are out-of-pocket unless secondary insurance covers.

Q: How often can I get new masks?

A: Medicare: every 3 months. Private plans: 3–6 months (check your policy).

Q: What if my supplier says “Medicare won’t pay”?

A: Ask for the exact denial reason code and review the EOB yourself. Many suppliers give up too early.

Q: Can I buy a used CPAP?

A: Yes, but Medicare and most private plans will not reimburse used equipment. Purchase must be new for coverage.

Conclusion

Getting a CPAP machine approved in 2025–2026 is still challenging, but the rules are clearer than ever before. The keys to success are:

1. Face-to-face visit before the sleep test
2. Sleep study that meets AHI criteria (≥15 or 5–14 + comorbidities)
3. Properly completed and timely signed CMN
4. Objective compliance data showing ≥4 hours/night on ≥70% of nights between days 31–91
5. Face-to-face re-evaluation documenting benefit
6. Appealing quickly and thoroughly when denied

Patients who understand the process, keep meticulous records, and partner with a knowledgeable sleep physician and DME supplier have approval rates above 85% on the first submission. You can be one of them.

Good luck—and breathe easier soon.

About the Author: Lone Movahid is a patient advocate and health literacy writer who has helped hundreds of people successfully navigate CPAP approval and appeals. She lives with treated sleep apnea and believes everyone deserves access to life-changing therapy without unnecessary red tape.

Durable Medical Equipment (DME) Coverage: Getting a CPAP Machine Approved